Loading…
Phio Pharmaceuticals Corp. is projected to rise to $1.18 by 2027, a +16% move from its current price of $1.02. PHIO is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $0.9933 | $1.02 | $1.05 | +0.01% |
| Jul 15 | $0.9825 | $1.02 | $1.06 | +0.03% |
| Jul 16 | $0.9744 | $1.02 | $1.07 | +0.04% |
| Jul 17 | $0.9676 | $1.02 | $1.08 | +0.06% |
| Jul 18 | $0.9617 | $1.02 | $1.08 | +0.07% |
| Jul 19 | $0.9563 | $1.02 | $1.09 | +0.09% |
| Jul 20 | $0.9515 | $1.02 | $1.10 | +0.10% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.9515 | $1.02 | $1.10 | +0.10% |
| Week 2 | $0.925 | $1.02 | $1.13 | +0.21% |
| Week 3 | $0.9054 | $1.02 | $1.16 | +0.31% |
| Week 4 | $0.8894 | $1.02 | $1.18 | +0.41% |
| Week 5 | $0.8756 | $1.03 | $1.20 | +0.51% |
| Week 6 | $0.8634 | $1.03 | $1.22 | +0.62% |
| Week 7 | $0.8524 | $1.03 | $1.24 | +0.72% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Phio Pharmaceuticals Corp. is a clinical stage biopharmaceutical company focused on immuno-oncology therapeutics in the United States.
It develops PH-762, an INTASYL compound designed to reduce the expression of PD-1 in multi-center Phase 1b dose-escalating clinical trials; PH-894, an INTASYL compound that is designed to silence BRD4, a protein that controls gene expression in both T cells and tumor cells in preclinical studies.
The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was founded in 2003 and is based in King Of Prussia, Pennsylvania.
PHIO is currently trading at $1.08 per share with a market capitalization of $12.55M.
It is ranked 5056 in market capitalization.
The forecast tailwinds suggest a long-run price outlook with upside potential: 2026 avg $1.08, 2030 avg $1.49, and 2050 avg $4.49, with a max forecast of $8.27 in 2050.
These figures are forecasts and not guarantees.
A major floor 15.7% below — a decisive break under it would weaken the trend.
The nearest floor, 5.9% below — buyers have tended to step in here.
The nearest ceiling, 11.8% above — a clean break opens room to run.
A major ceiling 29.4% above — clearing it would confirm fresh momentum.
Key PHIO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PHIO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.03 | Sell | $1.03 | Sell |
| MA 10 | $1.01 | Buy | $1.02 | Sell |
| MA 20 | $1.03 | Sell | $1.03 | Sell |
| MA 50 | $1.08 | Sell | $1.08 | Sell |
| MA 100 | $1.14 | Sell | $1.15 | Sell |
| MA 200 | $1.32 | Sell | $1.39 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 46.44 | Neutral |
| Stoch RSI (14) | 60.63 | Neutral |
| CCI (20) | -21.51 | Neutral |
| Williams %R (14) | -50.00 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | -1.92 | Sell |
| Bollinger %B (20,2) | 0.43 | Neutral |
| Stochastic %K (14) | 50.00 | Neutral |
| TRIX (15) | -0.34 | Sell |
| Awesome (5,34) | -0.03 | Sell |
| Ultimate (7,14,28) | 47.96 | Neutral |
| Momentum (10) | 0.06 | Buy |
| Aroon Osc (25) | -56.00 | Sell |
| Hull MA (9) | 1.05 | Sell |
| ADX (14) | 13.45 | Neutral |
| ATR (14) | 0.03 | Info |
Sentiment: NEUTRAL. RSI14: 50. SMA50: $1.09. SMA200: $1.33. Support: $0.96. Resistance: $1.14.
Thirty-day range: low $0.9039, high $1.29.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.857 | $1.02 | $1.23 | 0% | Neutral | |
| $0.9419 | $1.18 | $1.56 | +16% | Neutral | |
| $0.9935 | $1.28 | $1.76 | +25% | Bullish | |
| $1.05 | $1.39 | $1.96 | +36% | Bullish | |
| $1.03 | $1.39 | $2.01 | +36% | Bullish | |
| $0.951 | $1.30 | $1.92 | +28% | Bullish | |
| $1.01 | $1.40 | $2.11 | +37% | Bullish | |
| $1.07 | $1.51 | $2.31 | +48% | Bullish | |
| $1.19 | $1.71 | $2.66 | +68% | Bullish | |
| $1.30 | $1.90 | $2.99 | +86% | Bullish | |
| $1.48 | $2.31 | $3.87 | +126% | Bullish | |
| $2.36 | $4.10 | $7.52 | +302% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.857 | $1.02 | $1.21 | +0.00% |
| August 2026 | $0.8511 | $1.00 | $1.22 | -1.58% |
| September 2026 | $0.8704 | $1.03 | $1.27 | +2.97% |
| October 2026 | $0.8733 | $1.04 | $1.29 | +0.92% |
| November 2026 | $0.8343 | $1.00 | $1.25 | -3.99% |
| December 2026 | $0.8157 | $0.9839 | $1.23 | -1.78% |
Click any year to see its month-by-month PHIO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, PHIO could reach as high as $1.23, with a base case around $1.02 and support toward $0.857 — roughly 0% from $1.02. A consolidation phase looks the most probable path here.
Expect PHIO to range from $0.9419 to $1.56 through 2027. The $1.18 average target implies a +16% move from current prices. That is up +16% on the projected 2026 average. Price action looks broadly range-bound.
The PHIO price prediction for 2028 points to an average of $1.28 (low $0.9935, high $1.76) — a potential gain of +25% on today's $1.02. Buyers look set to stay in control over this stretch.
In 2029, PHIO is projected to trade between $1.05 and $1.96, averaging $1.39 — a potential gain of +36% from today's $1.02. That is up +8% on the projected 2028 average. Momentum favours further upside here.
Phio Pharmaceuticals Corp.'s 2030 outlook centres on $1.39, within a $1.03 to $2.01 range. That is 0% versus the projected 2029 average. That marks a +36% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, PHIO could reach as high as $1.92, with a base case around $1.30 and support toward $0.951 — roughly +28% from $1.02. Momentum favours further upside here.
Expect PHIO to range from $1.01 to $2.11 through 2032. The $1.40 average target implies a +37% move from current prices. That is up +8% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The PHIO price prediction for 2033 points to an average of $1.51 (low $1.07, high $2.31) — a potential gain of +48% on today's $1.02. Momentum favours further upside here.
In 2034, PHIO is projected to trade between $1.19 and $2.66, averaging $1.71 — a potential gain of +68% from today's $1.02. That is up +13% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Phio Pharmaceuticals Corp.'s 2035 outlook centres on $1.90, within a $1.30 to $2.99 range. That is up +11% on the projected 2034 average. That marks a +86% change versus current levels. Momentum favours further upside here.
By 2040, PHIO could reach as high as $3.87, with a base case around $2.31 and support toward $1.48 — roughly +126% from $1.02. Buyers look set to stay in control over this stretch.
Expect PHIO to range from $2.36 to $7.52 through 2050. The $4.10 average target implies a +302% move from current prices. That is up +78% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in PHIO today (≈ 980.392157 PHIO) could be worth
$4,020.98
+$3,020.98 (+302%) by 2050 · US Dollar
Based on the average projected PHIO price of $4.1 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PHIOwould be worth at today's price.
$1,000 invested in PHIO on Jul 10, 2025 (≈ 408.997966 PHIO) would be worth
$417.18
-$582.82 (-58.3%) today · 0.42× · US Dollar
Based on a PHIO entry price of $2.44 vs. today's $1.02.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1 | $1,020 | +2.0% |
| 1 month ago | $1.06 | $962.26 | -3.8% |
| 3 months ago | $1.21 | $842.98 | -15.7% |
| 6 months ago | $1.19 | $857.14 | -14.3% |
| 1 year ago | $2.44 | $417.18 | -58.3% |
| All time (5.0y) ago | $208.44 | $4.89 | -99.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PHIO forecast.
Our base-case forecast reaches $2.00 around 2040.
Implied market cap at $2.00: $23.23M
The multi-year forecast points to a bullish path from 2027 onward, with 2027 avg $1.27 and 2028 avg $1.37, 2029 avg $1.49, and 2030 avg $1.49, with corresponding ROI figures of 17.3%, 26.7%, 37.8%, and 37.7% respectively.
By 2040 the avg rises to $2.52 with a projected ROI of 133.7%, and by 2050 the avg is $4.49 with a projected ROI of 315.8%.
The sequence shows meaningful upside over time, though these are estimates and not guarantees, reflecting potential growth rather than a certainty.
Tap a question to reveal the answer.
The forecast for 2030 shows an avg price of $1.49 with a min of $1.10 and a max of $2.16, corresponding to an ROI of 37.7%.
The longer-term forecast envisions a bullish path, with 2050 avg $4.49 and 315.8% ROI, though these are estimates and not guarantees.
Yes. The 2035 forecast shows min $1.41, avg $2.07, max $3.27, indicating a potential to exceed $3 in a best-case scenario.
Current price is $1.08 and market cap is $12.55M.
The 30-day range runs from $0.9039 to $1.29, with sentiment NEUTRAL, RSI 50, SMA50 $1.09, SMA200 $1.33, support $0.96 and resistance $1.14.
Phio Pharmaceuticals Corp. Community Discussion
0Share your Phio Pharmaceuticals Corp. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.